Direct and simultaneous quantitation of 5-aminolaevulinic acid and porphobilinogen in human serum or plasma by hydrophilic interaction liquid chromatography-atmospheric pressure chemical ionization/tandem mass spectrometry

Biomedical Chromatography

Volumn 27, Issue 2, 2013, Pages 267-272

  Benton, Christopher M ^a,b   Couchman, Lewis ^a,b   Marsden, Joanne T ^a   Rees, David C ^a   Moniz, Caje ^a   Lim, Chang Kee ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

5 aminolaevulinic acid; Acute hepatic porphyrias; HILIC; Porphobilinogen; Tandem mass spectrometry

Indexed keywords

ATMOSPHERIC CHEMISTRY; ATMOSPHERIC IONIZATION; BODY FLUIDS; DIAGNOSIS; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT TREATMENT;

5-AMINOLAEVULINIC ACID; 5-AMINOLEVULINIC ACID; ACUTE HEPATIC PORPHYRIA; ATMOSPHERIC PRESSURE CHEMICAL IONIZATION; HEPATIC PORPHYRIA; HILIC; HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHIES; PORPHOBILINOGEN; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY;

ATMOSPHERIC PRESSURE;

AMINOLEVULINIC ACID; PORPHOBILINOGEN;

ACCURACY; AMINO ACID BLOOD LEVEL; ARTICLE; CALIBRATION; CONTROLLED STUDY; HEPATIC PORPHYRIA; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIMIT OF QUANTITATION; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MONITORING; PRECIPITATION; SCREENING; TANDEM MASS SPECTROMETRY;

EID: 84871959561     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2843     Document Type: Article

References (12)

1. Benton CM and Lim CK. Liquid chromatography and mass spectrometry of haem biosynthetic intermediates: a review. Biomedical Chromatography 2012; 26: 1009-1023.
2. Benton CM, Couchman C, Marsden JT, Rees DC, Moniz C and Lim CK. Direct and simultaneous determination of 5-aminolaevulinic acid and porphobilinogen in urine by hydrophilic interaction liquid chromatography-electrospray ionisation/tandem mass spectrometry. Biomedical Chromatography 2012a; 26: 1033-1040.
3. Benton CM, Moniz C, Lim CK and Jones DJL. Travelling wave ion mobility spectrometry mass spectrometry of 5-aminolaevulinic acid, porphobilinogen and porphyrins. Rapid Communications in Mass Spectrometry 2012b; 26: 480-486.
4. Bonfiglio R, King RC, Olah TV and Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Communications in Mass Spectrometry 1999; 13: 1175-1185.
5. Deacon AC and Elder GH. Front line tests for the investigation of suspected porphyria. Journal of Clinical Pathology 2001; 54: 500-507.
6. Floderus Y, Sardh E, Möller C, Andersson C, Rejkjaer L, Andersson DEH and Harper P. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Clinical Chemistry 2006; 52: 701-707.
7. Gorchein A. Determination of δ-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection. Biochemical Journal 1984; 219: 883-889.
8. Jaffe EK and Smith L. ALAD porphyria is a conformational disease. American Journal of Human Genetics 2007; 80: 329-337.
9. Lord GA, Luo JL and Lim CK. Capillary zone electrophoresis/mass spectrometry of 5-aminolaevulinic acid and porphobilinogen. Rapid Communications in Mass Spectrometry 2000; 14: 314-316.
10. Puy H, Gouya L and Deybach JC. Porphyrias. Lancet 2010; 375: 924-937.
11. Sardh E, Harper P, Andersson DE and Floderus Y. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. European Journal of Internal Medicine 2009; 20: 201-207.
12. Zhang J, Yasuda M, Desnick RJ, Balwani M, Bishop D and Yu C. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen. Journal of Chromatography B 2011; 879: 2389-2396.